Ratings Garofalo Health Care S.p.A.

Equities

GHC

IT0005345233

Market Closed - Borsa Italiana 11:44:59 2024-02-21 am EST 5-day change 1st Jan Change
4.79 EUR 0.00% Intraday chart for Garofalo Health Care S.p.A. -1.44% +3.23%

Strengths

  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
+3.23% 459 M $
B
-8.03% 18 879 M $
B+
-6.66% 15 957 M $
A-
+2.70% 12 612 M $
B
+18.75% 11 723 M $
B+
+2.82% 11 386 M $
B+
-3.48% 7 552 M $
A-
+11.71% 7 471 M $
B
+9.55% 6 910 M $
B-
+12.88% 6 730 M $
D
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer